Medical imaging could be dramatically underutilized due to an outdated fear that may be denying patients critical diagnostic procedures. For decades, physicians have avoided or delayed contrast-enhanced imaging out of concern for kidney damage, but this caution appears increasingly misplaced given modern evidence.
Contemporary propensity-matched studies and randomized controlled trials consistently demonstrate that current low-osmolar and iso-osmolar contrast agents rarely cause genuine kidney injury, even in high-risk populations including patients with advanced chronic kidney disease, existing acute kidney injury, or critical illness. The landmark Prevention of Serious Adverse Events Following Angiography trial found no meaningful differences between preventive strategies like sodium bicarbonate versus saline hydration, while highlighting that aggressive fluid protocols can actually cause harm through fluid overload.
This disconnect between clinical practice and evidence represents a significant shift from nephrology's traditional understanding. The original fears stemmed from 1950s case reports involving high-osmolar contrast agents that are no longer used, yet the clinical mythology has persisted despite technological advances. The phenomenon termed "renalism" - unnecessary avoidance of essential imaging - may actually worsen patient outcomes by delaying critical diagnoses. Current evidence suggests individualized risk assessment should replace blanket avoidance protocols. For most patients, including those with moderate kidney impairment, the diagnostic benefits of contrast imaging likely outweigh minimal nephrotoxic risks. This represents a paradigm shift requiring clinicians to recalibrate their risk-benefit calculations and abandon defensive practices rooted in outdated data.